|
| Press Releases |
|
 |
|
| Monday, July 31, 2023 |
|
|
China Medical System Once Again Received MSCI-ESG 'AA' Rating, Leading the Industry in ESG Management |
| Recently, MSCI (Morgan Stanley Capital International), the world's largest index company, announced the latest Environmental, Social, and Governance (ESG) evaluation report for China Medical System Holdings limited ("CMS" or the "Group"), who achieved an "AA" rating and surpassed 75% of global peers with leading ESG management practices. more info >> |
|
| Thursday, June 29, 2023 |
|
|
China Medical System Included in the First 'Sustainability Yearbook (China)' of S&P Global |
| more info >> |
|
| Monday, June 12, 2023 |
|
|
China Medical System: The first 'Diazepam Nasal Spray' Approved for Marketing in China |
| more info >> |
|
|
China Medical System: The first 'Diazepam Nasal Spray' Approved for Marketing in China |
| more info >> |
|
| Tuesday, May 30, 2023 |
|
|
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China |
| On May 30, China Medical System Holdings Limited ("CMS" or the "Group") announced that on 26 May 2023, the New Drug Application (NDA) of Tildrakizumab Injection under the brand name of ILUMETRI has been approved by the National Medical Products Administration of China (NMPA). ILUMETRI is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. more info >> |
|
|
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China |
| On May 30, China Medical System Holdings Limited ("CMS" or the "Group") announced that on 26 May 2023, the New Drug Application (NDA) of Tildrakizumab Injection under the brand name of ILUMETRI has been approved by the National Medical Products Administration of China (NMPA). ILUMETRI is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. more info >> |
|
| Monday, December 19, 2022 |
|
|
Gelonghui Reports CMS' Successful Phase III Study of Methylthioninium Chloride Enteric-coated Sustained-release Tablets |
| Gelonghui released a Press Release on "China Medical System Holdings Limited's innovative product Methylthioninium Chloride Enteric-coated Sustained-release Tablets ('the Product') has obtained positive results for its Phase III clinical trial in China." more info >> |
|
| Friday, November 18, 2022 |
|
|
China Medical System (867.HK) S&P Global CSA Score Achieved Significant Improvement, Leading the Industry Globally |
| Recently, the S&P Global Corporate Sustainability Assessment (S&P Global CSA) released the 2022 Environmental, Social and Governance (ESG) scores for China Medical System Holdings Limited ("CMS" or the "Group"). CMS achieved a significant improvement with a score of 53 in 2022 from 36 in 2021, surpassing 92% of the global peers and being significantly ahead of the industry average. more info >> |
|
| Friday, August 26, 2022 |
|
|
CMS Releases Its 2022 Interim Report, Achieves Sustained Growth with Its Platform Strategy |
| more info >> |
|
| Tuesday, September 6, 2022 |
|
|
CMS Releases Its 2022 Interim Report, Achieves Sustained Growth with Its Platform Strategy |
| more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Honda、「CIVIC」をマイナーモデルチェンジし発売
Sept 12, 2024 11:00: JST
|
|
|
"Ashes of the Kingdom" Breaks Barriers to Captivate the World: Chinese Female-Oriented Games Showcase Global Impact
Sept 11, 2024 23:00 HKT/SGT
|
|
|
Pixotope Forges Strategic Partnership with Happy Elephant Consortium for Asia-Pacific Expansion
Sept 11, 2024 21:00: JST
|
|
|
Pixotope與Happy Elephant Consortium達成戰略合作夥伴關係，推動亞太地區擴展
Sept 11, 2024 20:00 HKT/SGT
|
|
|
Pixotope与Happy Elephant Consortium达成战略合作伙伴关系，推动亚太地区扩展
Sept 11, 2024 20:00 HKT/SGT
|
|
|
Pixotope Forges Strategic Partnership with Happy Elephant Consortium for Asia-Pacific Expansion
Sept 11, 2024 20:00 HKT/SGT
|
|
|
Sculpting Reimagined: Maxon Releases ZBrush for iPad
Sept 11, 2024 20:00 HKT/SGT
|
|
|
Belt and Road Summit Opened Today
Sept 11, 2024 18:22 HKT/SGT
|
|
|
Moody's Reaffirms GTJAI's 'Baa2' Long-term Issuer Rating with a 'Stable' Outlook
Sept 11, 2024 17:28 HKT/SGT
|
|
|
國泰君安國際獲穆迪重申“Baa2” 長期發行人評級，展望“穩定”
Sept 11, 2024 17:12 HKT/SGT
|
|
|
国泰君安国际获穆迪重申“Baa2” 长期发行人评级，展望“稳定”
Sept 11, 2024 17:06 HKT/SGT
|
|
|
Honda Begins Joint Research on AI Technologies with the Indian Institutes of Technology in Delhi and Bombay to Further Advance Honda CI (Cooperative Intelligence)
Sept 11, 2024 16:10 JST
|
|
|
MHI-MS、駐車場などでの自動バレーパーキング、完成車自動搬送向け事業展開を加速
Sept 11, 2024 14:30: JST
|
|
|
Honda、協調人工知能Honda CIのさらなる進化を目指し、インド工科大学デリー校およびボンベイ校とAI技術の共同研究を開始
Sept 11, 2024 14:30: JST
|
|
|
EASD 2024 | 君圣泰医药口头报告熊去氧胆小檗碱（HTD1801）在T2DM中的两项事后分析
Sept 11, 2024 11:51 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
